Corestate Capital (CCAP) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
13 Jun, 2025Executive summary
Real estate market remains challenging, but stabilization is expected from late 2024; strategic realignment and cost reduction are progressing.
Focus is on asset and investment management via Hannover Leasing and STAM France; asset monetization and targeted investments continue.
Financial highlights
Aggregated revenue and gains for Q1 2024 were €7.8m, down from €9.1m in Q1 2023.
EBITDA for Q1 2024 was €-7.1m, improved from €-15.2m in Q1 2023; adjusted EBITDA was €-6.1m.
Net profit for Q1 2024 was €-14.5m, compared to €-23.5m in Q1 2023; adjusted net profit was €-12.6m.
Earnings per share improved to €-0.09 from €-0.14 year-over-year.
Cash and cash equivalents at March 31, 2024, were €23.1m, down from €42.9m at year-end 2023.
Outlook and guidance
Management expects market stabilization from end of 2024; asset monetization program is on track but delayed by about six months.
By year-end 2024, aims to make interest payments in cash and potentially repay part of Senior Notes if liquidity exceeds €25m.
Asset disposals planned at €65.8m for 2024, with €4.5m realized in Q1 and €13.7m additional inflows by end of May.
Latest events from Corestate Capital
- Significant losses and deleveraging mark a challenging transition to a holding structure.CCAP
Q3 20255 Jan 2026 - Revenue and EBITDA fell, but asset sales and liquidity support ongoing deleveraging.CCAP
Q2 20255 Sep 2025 - Restructuring nearly complete; focus shifts to asset sales and deleveraging amid market headwinds.CCAP
Q4 20248 Aug 2025 - Revenue up, profits down; asset sales and debt repayment drive 2025 strategy.CCAP
Q1 202517 Jun 2025 - Net loss, lower equity, and delayed asset sales mark Corestate's ongoing restructuring.CCAP
Q3 202413 Jun 2025 - EBITDA loss narrowed and asset sales accelerated, but AUM and equity ratio declined.CCAP
Q2 202413 Jun 2025